A Peptide from Thrombospondin 1 Modulates Experimental Erosive Arthritis by Regulating Connective Tissue Growth Factor
-
2006/08/01
Details
-
Personal Author:Agelan A ; Arango I ; Barbe MF ; Castaneda J ; DeLa Cadena RA ; Manns JM ; Popoff SN ; Rico MC ; Safadi FF ; Uknis AB
-
Description:Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with leukocyte adhesion to and extravasation through vascular endothelium into synovial tissue. Recent evidence indicates that the thrombospondin 1 gene is up-regulated in patients with RA. We have identified a region within the TSP-1 type 3 repeats that inhibits human neutrophil elastase (HNE) and binds to human neutrophils. The present study was undertaken to investigate the therapeutic benefit of this TSP-1-derived peptide sequence and its effect on connective tissue growth factor (CTGF), a protein involved in fibrotic disorders and in neovascularization, which is a hallmark of RA. CTGF gene and protein expression, as well as protein levels of CTGF in the synovium, after treatment with the TSP-1-derived peptide were studied in the peptidoglycan-polysaccharide animal model of erosive arthritis. Peptide treatment prevented joint infiltration and inflammation and was associated with reduced circulating antigen levels of HNE and TSP-1. Additionally, CTGF was up-regulated in this experimental model of RA. Treatment with the TSP-1-derived peptide was associated with down-regulation of the message and protein levels of CTGF. Immunofluorescence studies showed that the mean area fraction of CTGF immunoreactivity in the peptide-treated group of animals was significantly less than that in the untreated group. These results document a role for TSP-1 in regulating CTGF gene and protein expression in synovial tissue, suggesting a link with the disease course in this model of RA. This TSP-1-derived synthetic peptide may represent an important template for drug development in RA and other inflammatory conditions associated with neutrophil activation. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0004-3591
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:54
-
Issue:8
-
NIOSHTIC Number:nn:20030981
-
Citation:Arthritis Rheum 2006 Aug; 54(8):2415-2422
-
Contact Point Address:Joanne M. Manns, Temple University School of Medicine, Department of Physiology 230 B OMS, 3400 North Broad Street, Philadelphia, PA 19140
-
Email:mannsjm@temple.edu
-
Federal Fiscal Year:2006
-
NORA Priority Area:
-
Performing Organization:Temple University
-
Peer Reviewed:True
-
Start Date:20000601
-
Source Full Name:Arthritis and Rheumatism
-
End Date:20120731
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e8835b437abad398fc22d8685d9f22b4b50be3750977ad4339d86a27e0a535691e277891ad3bc9f2d79dc1658dcb699811d506aa54a949a1ac88d5d9551debb1
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like